Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats

Abstract Perillyl alcohol (POH) has been extensively studied for the treatment of peripheral and primary brain tumors. The intranasal route of administration has been preferred for dosing POH in early-stage clinical trials associated with promising outcomes in primary brain cancer. However, it is un...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Geetika Nehra, Shannon Andrews, Joan Rettig, Michael N. Gould, Jill D. Haag, Steven P. Howard, Robert G. Thorne
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/10ae0b670c5e46fc889e1453f7c66a14
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:10ae0b670c5e46fc889e1453f7c66a14
record_format dspace
spelling oai:doaj.org-article:10ae0b670c5e46fc889e1453f7c66a142021-12-02T17:05:46ZIntranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats10.1038/s41598-021-85293-42045-2322https://doaj.org/article/10ae0b670c5e46fc889e1453f7c66a142021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85293-4https://doaj.org/toc/2045-2322Abstract Perillyl alcohol (POH) has been extensively studied for the treatment of peripheral and primary brain tumors. The intranasal route of administration has been preferred for dosing POH in early-stage clinical trials associated with promising outcomes in primary brain cancer. However, it is unclear how intranasal POH targets brain tumors in these patients. Multiple studies indicate that intranasally applied large molecules may enter the brain and cerebrospinal fluid (CSF) through direct olfactory and trigeminal nerve-associated pathways originating in the nasal mucosa that bypass the blood–brain barrier. It is unknown whether POH, a small molecule subject to extensive nasal metabolism and systemic absorption, may also undergo direct transport to brain or CSF from the nasal mucosa. Here, we compared CSF and plasma concentrations of POH and its metabolite, perillic acid (PA), following intranasal or intravascular POH application. Samples were collected over 70 min and assayed by high-performance liquid chromatography. Intranasal administration resulted in tenfold higher CSF-to-plasma ratios for POH and tenfold higher CSF levels for PA compared to equal dose intravascular administration. Our preclinical results demonstrate POH undergoes direct transport from the nasal mucosa to the CSF, a finding with potential significance for its efficacy as an intranasal chemotherapeutic for brain cancer.Geetika NehraShannon AndrewsJoan RettigMichael N. GouldJill D. HaagSteven P. HowardRobert G. ThorneNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Geetika Nehra
Shannon Andrews
Joan Rettig
Michael N. Gould
Jill D. Haag
Steven P. Howard
Robert G. Thorne
Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats
description Abstract Perillyl alcohol (POH) has been extensively studied for the treatment of peripheral and primary brain tumors. The intranasal route of administration has been preferred for dosing POH in early-stage clinical trials associated with promising outcomes in primary brain cancer. However, it is unclear how intranasal POH targets brain tumors in these patients. Multiple studies indicate that intranasally applied large molecules may enter the brain and cerebrospinal fluid (CSF) through direct olfactory and trigeminal nerve-associated pathways originating in the nasal mucosa that bypass the blood–brain barrier. It is unknown whether POH, a small molecule subject to extensive nasal metabolism and systemic absorption, may also undergo direct transport to brain or CSF from the nasal mucosa. Here, we compared CSF and plasma concentrations of POH and its metabolite, perillic acid (PA), following intranasal or intravascular POH application. Samples were collected over 70 min and assayed by high-performance liquid chromatography. Intranasal administration resulted in tenfold higher CSF-to-plasma ratios for POH and tenfold higher CSF levels for PA compared to equal dose intravascular administration. Our preclinical results demonstrate POH undergoes direct transport from the nasal mucosa to the CSF, a finding with potential significance for its efficacy as an intranasal chemotherapeutic for brain cancer.
format article
author Geetika Nehra
Shannon Andrews
Joan Rettig
Michael N. Gould
Jill D. Haag
Steven P. Howard
Robert G. Thorne
author_facet Geetika Nehra
Shannon Andrews
Joan Rettig
Michael N. Gould
Jill D. Haag
Steven P. Howard
Robert G. Thorne
author_sort Geetika Nehra
title Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats
title_short Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats
title_full Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats
title_fullStr Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats
title_full_unstemmed Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats
title_sort intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/10ae0b670c5e46fc889e1453f7c66a14
work_keys_str_mv AT geetikanehra intranasaladministrationofthechemotherapeuticperillylalcoholresultsinselectivedeliverytothecerebrospinalfluidinrats
AT shannonandrews intranasaladministrationofthechemotherapeuticperillylalcoholresultsinselectivedeliverytothecerebrospinalfluidinrats
AT joanrettig intranasaladministrationofthechemotherapeuticperillylalcoholresultsinselectivedeliverytothecerebrospinalfluidinrats
AT michaelngould intranasaladministrationofthechemotherapeuticperillylalcoholresultsinselectivedeliverytothecerebrospinalfluidinrats
AT jilldhaag intranasaladministrationofthechemotherapeuticperillylalcoholresultsinselectivedeliverytothecerebrospinalfluidinrats
AT stevenphoward intranasaladministrationofthechemotherapeuticperillylalcoholresultsinselectivedeliverytothecerebrospinalfluidinrats
AT robertgthorne intranasaladministrationofthechemotherapeuticperillylalcoholresultsinselectivedeliverytothecerebrospinalfluidinrats
_version_ 1718381774495547392